Clinical trial
Abuse Potential of Buprenorphine/Naloxone
NCT00149539 · National Institute on Drug Abuse (NIDA), NIH · Terminated
Key facts
| NCT number | NCT00149539 |
|---|---|
| Title | Abuse Potential of Buprenorphine/Naloxone |
| Official title | Abuse Potential of Buprenorphine/Naloxone as a Function of Maintenance Dose of Buprenorphine/Naloxone |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Collaborators | Johns Hopkins University |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Opioid-Related Disorders |
| Intervention type | Drug |
| Interventions | Buprenorphine/naloxone |
| Enrollment | 12 |
| Start date | Jun 1, 2004 |
| Completion | Jan 1, 2006 |
| First posted | Sep 8, 2005 |
| Last update posted | Jan 12, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: